Trichomonas vaginalis exosomes: Mediators of host:pathogen interactions

阴道毛滴虫外泌体:宿主:病原体相互作用的介质

基本信息

项目摘要

DESCRIPTION (provided by applicant): The unicellular parasite Trichomonas vaginalis is responsible for the most prevalent non-viral sexually transmitted infection worldwide, with approximately 170 million cases of trichomoniasis reported annually. In the US alone, the annual incidence is estimated at 3-5 million cases. In addition to infecting the human urogenital tract, trichomoniasis increases the risk of adverse pregnancy outcomes, HIV transmission and the incidence and severity of cervical and prostate cancers. It's prevalence and the recent increase in the number of drug resistant T. vaginalis strains underscore the need to develop new chemotherapeutic and vaccine design strategies. A much better understanding of processes involved in infectivity and pathogenesis, such as those proposed here, will be imperative to achieve these goals. We have discovered that T. vaginalis secretes small, membrane-bound vesicles, called exosomes, which are capable of fusing with and delivering proteins into the host cell. Parasite exosomes can also modulate host cell responses. The exosome-mediated host:pathogen interactions that we observed is an entirely new area of research that promises to uncover interesting, novel mechanisms. Our objectives are to further characterize exosome:host cell interactions and investigate the effect of exosomes on global host cell response. To this end, our studies will focus on characterizing exosomal fusion with host cells and exosome-mediated modulation of host cell gene and protein expression. The specfic aims of the proposal are: Aim 1: Determine whether the conserved exosomal membrane protein, tetraspanin 1, plays a vital role in exosome fusion with host cells and if this is mediate by selection of specific exosomal membrane-associated proteins. Aim 2: Determine whether exosomes from highly adherent and cytolytic T. vaginalis strains increase the ability of weakly adherent/cytolytic strains to adhere to and/or lyse vaginal epithelial cells. The exosomal proteomes of these strains will also be compared to identify candidate proteins involved in adherence and cytolysis. Aim 3: [Examine how] T. vaginalis exosomes modulate host cell responses by altering gene and protein expression in target human vaginal epithelial cells. These studies will greatly enhance our understanding of processes underlying the infectivity and pathogenesis of a prevalent human pathogen and have a high probability of revealing novel mechanisms used by the parasite to mediate host:pathogen interactions. As exosomes are also produced by mammalian cells and are known to play critical roles in both normal and pathological cellular functions, what we learn from the proposed studies is likely to also contribute to a better understanding of the role of exosomes in development, antigen presentation, immune modulation and cancer metastasis.
描述(由申请人提供):单细胞寄生虫阴道毛原虫是全球最普遍的非病毒性传播感染的罪魁祸首,每年报告约1.7亿例阴道毛原虫病病例。仅在美国,每年的发病率估计为300万至500万例。除了感染人类泌尿生殖道外,滴虫病还增加了不良妊娠结局、艾滋病毒传播以及宫颈癌和前列腺癌的发病率和严重程度的风险。它的流行和最近耐药T细胞数量的增加。迷走病毒株强调了开发新的化疗和疫苗设计策略的需要。更好地理解感染性和发病机制所涉及的过程,如本文所提出的,将是实现这些目标的必要条件。我们发现T.迷走神经分泌小的膜结合囊泡,称为外泌体,其能够与宿主细胞融合并将蛋白质递送到宿主细胞中。寄生虫外泌体也可以调节宿主细胞反应。我们观察到的外泌体介导的宿主:病原体相互作用是一个全新的研究领域,有望揭示有趣的新机制。我们的目标是进一步表征外泌体与宿主细胞的相互作用,并研究外泌体对整体宿主细胞反应的影响。为此,我们的研究将集中在表征外泌体与宿主细胞的融合以及外泌体介导的宿主细胞基因和蛋白质表达的调节。目的1:确定保守的外泌体膜蛋白tetraspanin 1是否在外泌体与宿主细胞融合中起重要作用,以及这是否通过选择特定的外泌体膜相关蛋白介导。目的2:确定来自高粘附性和细胞溶解性T。阴道炎菌株增加弱粘附/细胞溶解菌株粘附和/或溶解阴道上皮细胞的能力。还将比较这些菌株的外泌体蛋白质组以鉴定参与粘附和细胞溶解的候选蛋白质。目标3:[检查如何] T。阴道外泌体通过改变靶人阴道上皮细胞中的基因和蛋白质表达来调节宿主细胞反应。这些研究将极大地提高我们的理解的过程的感染性和发病机制的流行的人类病原体,并有很大的可能性揭示新的机制,寄生虫介导宿主:病原体相互作用。由于外泌体也由哺乳动物细胞产生,并且已知在正常和病理细胞功能中发挥关键作用,因此我们从拟议的研究中了解到的内容也可能有助于更好地理解外泌体在发育,抗原呈递,免疫调节和癌症转移中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patricia Jean Johnson其他文献

Patricia Jean Johnson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patricia Jean Johnson', 18)}}的其他基金

Identification of key players mediating internalization of Trichomonas vaginalis extracellular vesicles by host cells and parasite adherence and survival in vivo
宿主细胞介导阴道毛滴虫细胞外囊泡内化的关键参与者的鉴定以及寄生虫在体内的粘附和存活
  • 批准号:
    10177862
  • 财政年份:
    2020
  • 资助金额:
    $ 59.36万
  • 项目类别:
Identification of key players mediating internalization of Trichomonas vaginalis extracellular vesicles by host cells and parasite adherence and survival in vivo
宿主细胞介导阴道毛滴虫细胞外囊泡内化的关键参与者的鉴定以及寄生虫在体内的粘附和存活
  • 批准号:
    10410401
  • 财政年份:
    2020
  • 资助金额:
    $ 59.36万
  • 项目类别:
Inhibitors of Nitro Drug Targets as Antimicrobials against Trichomonas Vaginalis
硝基药物靶点抑制剂作为阴道毛滴虫抗菌药物
  • 批准号:
    9089977
  • 财政年份:
    2015
  • 资助金额:
    $ 59.36万
  • 项目类别:
Trichomonas vaginalis exosomes: Mediators of host:pathogen interactions
阴道毛滴虫外泌体:宿主:病原体相互作用的介质
  • 批准号:
    8579476
  • 财政年份:
    2013
  • 资助金额:
    $ 59.36万
  • 项目类别:
Trichomonas vaginalis MIF: a role in prostate cancer and infertility?
阴道毛滴虫 MIF:在前列腺癌和不孕症中的作用?
  • 批准号:
    8493682
  • 财政年份:
    2013
  • 资助金额:
    $ 59.36万
  • 项目类别:
Trichomonas vaginalis MIF: a role in prostate cancer and infertility?
阴道毛滴虫 MIF:在前列腺癌和不孕症中的作用?
  • 批准号:
    8716664
  • 财政年份:
    2013
  • 资助金额:
    $ 59.36万
  • 项目类别:
Role of tetraspanin proteins in Trichomonas vaginalis pathogenesis
四跨膜蛋白在阴道毛滴虫发病机制中的作用
  • 批准号:
    8633482
  • 财政年份:
    2013
  • 资助金额:
    $ 59.36万
  • 项目类别:
Trichomonas vaginalis exosomes: Mediators of host:pathogen interactions
阴道毛滴虫外泌体:宿主:病原体相互作用的介质
  • 批准号:
    8666715
  • 财政年份:
    2013
  • 资助金额:
    $ 59.36万
  • 项目类别:
Role of tetraspanin proteins in Trichomonas vaginalis pathogenesis
四跨膜蛋白在阴道毛滴虫发病机制中的作用
  • 批准号:
    8410373
  • 财政年份:
    2013
  • 资助金额:
    $ 59.36万
  • 项目类别:
Trichomonas vaginalis exosomes: Mediators of host:pathogen interactions
阴道毛滴虫外泌体:宿主:病原体相互作用的介质
  • 批准号:
    9063979
  • 财政年份:
    2013
  • 资助金额:
    $ 59.36万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 59.36万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 59.36万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 59.36万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 59.36万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 59.36万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 59.36万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 59.36万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 59.36万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 59.36万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 59.36万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了